Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,720 | 2,066 | 746 | 2,338 | 4,357 |
| Marketable Securities | 0 | 0 | N/A | 0 | 500 |
| Other current assets | 0 | 0 | 424 | 0 | 0 |
| TOTAL | $1,827 | $2,233 | $1,382 | $2,557 | $4,986 |
| Non-Current Assets | |||||
| Intangibles | 2,364 | 2,039 | 2,039 | 2,039 | 2,039 |
| Other Non-Current Assets | 76 | 85 | 94 | 102 | 111 |
| TOTAL | $2,440 | $2,124 | $2,133 | $2,141 | $2,150 |
| Total Assets | $4,267 | $4,357 | $3,515 | $4,698 | $7,136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,900 | 4,867 | 2,768 | 1,737 | 663 |
| Accrued Expenses | 46 | 18 | N/A | N/A | N/A |
| TOTAL | $4,860 | $5,712 | $2,804 | $1,772 | $697 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40 | 51 | 59 | 69 | 78 |
| TOTAL | $40 | $51 | $59 | $69 | $78 |
| Total Liabilities | $4,900 | $5,763 | $2,863 | $1,841 | $775 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,019 | 1,322 | 547 | 547 | 538 |
| Common Shares | 2 | 1 | 3 | 1 | 3 |
| Retained earnings | -58,849 | -55,729 | -52,508 | -50,136 | -46,358 |
| Other shareholders' equity | -277 | -295 | -227 | -202 | -218 |
| TOTAL | $-633 | $-1,406 | $652 | $2,857 | $6,361 |
| Total Liabilities And Equity | $4,267 | $4,357 | $3,515 | $4,698 | $7,136 |